Please Wait
Applying Filters...
menu
    • menu
    FDA approvals drop 24% in H1 2025; GSK’s UTI med, Vertex’s non-opioid painkiller lead pack of first-in-class meds

    Data Compilation
    #PharmaFlow

    Pipeline Prospector August 2025: Novo’s Wegovy approved for MASH, Tonix Pharma’s fibromyalgia drug okayed

    Stock Recap
    #PipelineProspector

    Menu

    Docusate Sodium Salt

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 17Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to access your PharmaMiles and download the data

    Last Updated on PharmaCompass Virtual Booth Country Name of the Firm Written Confirmation No. Product Name Issue Date Valid Till Address of the Firm
    06/09/2025 Badrivishal Chemicals & Pharmaceuticals
    India
    		 M/s Badrivishal Chemicals and Pharmaceuticals WC-0515 Docusate Sodium IP/BP/USP/Ph.Eur. 05-08-2025 09-12-2027 GAT No. 29, Village-Jambwade (Induri), Post - Sudumbre, Tal- Maval, Pune, Maharashtra- 412109, India.